Guidance for industry [electronic resource] : nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV), testing, product disposition, and donor deferral and reentry.
Imprint
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2005]
Mode of access: Internet at the FDA CBER web site. Address as of 5/19/09: http://www.fda.gov/cber/gdlns/nathivhcv.pdf ; current access is available via PURL.
Note
Title from PDF title page (viewed on May 19, 2009).
"Draft guidance."
"July 2005."
Bibliography
Includes bibliographical references (pages 24-25).
Nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis c virus (HCV), testing, product disposition, and donor deferral and reentry
